Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

University of Kentucky

Superfund Research Program

Superfund Chemicals: Transport, Metabolism and Toxicity

Center Director: Bernhard Hennig
Grant Number: P42ES007380
Funding Period: 1997-2025

Learn More About the Grantee

Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Video page

Summary (2000-2005)

The University of Kentucky Superfund Basic Research Program began in 1997 and consists of seven projects (5 biomedical, 2 non-biomedical), a research support core (synthesis), and administrative, training and outreach cores. The goals of this program are: (1) mechanistic investigations of the adverse effects of PCBs and related halogenated compounds; (2) detection of biomarkers of exposure and toxicity; (3) development of highly sensitive and specific sensing systems; and (4) development of advanced remediation techniques and methods of destruction. Three projects are related to PCB effects on phases of carcinogenesis and include studies on: (1) characterizing the activation and genotoxic profile of PCB metabolites; (2) the mechanism of hepatic tumor promotion of PCBs and the role of oxidative stress leading to changes in gene expression; and (3) intercellular adhesion molecules and the mechanism by which PCBs may enhance the development of tumor metastasis. One project examines how PCBs target vascular endothelium and the role of specific dietary fats to potentiate PCB-mediated endothelial dysfunction and specific nutrient interventions that may provide protection against PCB/lipid-mediated atherosclerosis. The final biomedical project is providing an integrated, multidisciplinary, multispecies approach to understanding endpoints and mechanisms of action of endocrine disrupting PCBs. One non-biomedical project is developing optical and electrochemical biosensing systems for PCBs based on recombinant bacteria that incorporate catabolic pathways for PCBs, along with the expression of reporter genes, and mammalian and yeast systems that couple reporter gene expression with binding of the contaminant to the aromatic hydrocarbon receptor. The second non-biomedical project is investigating dehalogenation as a remediation strategy for chlorinated organics. Specifically, the role of the reductive agent morphology on optimizing destruction of chlorinated organics is being studied.

Back
to Top